Average Co-Inventor Count = 5.18
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Arena Pharmaceuticals, Inc. (17 from 216 patents)
2. Mirati Therapeutics, Inc. (2 from 38 patents)
3. Merck + Co., Inc. (1 from 4,770 patents)
19 patents:
1. 12286431 - Crystalline forms of a KRas G12C inhibitor
2. 12281113 - Crystalline forms of a KRas G12C inhibitor
3. 11674163 - Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
4. 11149292 - Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
5. 10787437 - Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor
6. 10059691 - Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor
7. 9783502 - [object Object]
8. 9556149 - Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor
9. 9447041 - Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
10. 9199940 - [object Object]
11. 9175320 - Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
12. 9085581 - Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof
13. 8853419 - [object Object]
14. 8822727 - [object Object]
15. 8637555 - Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof